PSTV vs. TNYA
PSTV (Plus Therapeutics Inc) and TNYA (Tenaya Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, PSTV returned -62.09%/yr vs -49.80%/yr for TNYA. At a 0.17 correlation, their price movements are largely independent.
Performance
PSTV vs. TNYA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PSTV achieves a -68.14% return, which is significantly lower than TNYA's 2.04% return.
PSTV
- 1D
- 2.51%
- 1M
- -38.09%
- YTD
- -68.14%
- 6M
- -70.27%
- 1Y
- -11.45%
- 3Y*
- -62.09%
- 5Y*
- -67.02%
- 10Y*
- -68.14%
TNYA
- 1D
- 3.71%
- 1M
- -6.02%
- YTD
- 2.04%
- 6M
- 3.24%
- 1Y
- 29.97%
- 3Y*
- -49.80%
- 5Y*
- —
- 10Y*
- —
PSTV vs. TNYA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
PSTV Plus Therapeutics Inc | -68.14% | -55.45% | -34.29% | -63.19% | -69.81% | -46.15% |
TNYA Tenaya Therapeutics, Inc. | 2.04% | -50.24% | -55.86% | 61.19% | -89.39% | -2.82% |
Correlation
The correlation between PSTV and TNYA is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021 | 0.17 |
Fundamentals
PSTV:
$27.12M
TNYA:
$157.46M
PSTV:
-$4.87
TNYA:
-$0.48
PSTV:
2.41
TNYA:
561.43
PSTV:
2.27
TNYA:
1.48
PSTV:
$4.15M
TNYA:
$225.00K
PSTV:
$3.89M
TNYA:
$0.00
PSTV:
-$1.39M
TNYA:
-$78.62M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PSTV vs. TNYA — Risk / Return Rank
PSTV
TNYA
PSTV vs. TNYA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Plus Therapeutics Inc (PSTV) and Tenaya Therapeutics, Inc. (TNYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PSTV | TNYA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.35 | ||
| Sortino ratioReturn per unit of downside risk | -0.19 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.15 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | -0.13 | 0.41 | -0.54 |
| Martin ratioReturn relative to average drawdown | -0.21 | 0.62 | -0.83 |
Loading charts...
Drawdowns
PSTV vs. TNYA - Drawdown Comparison
The maximum PSTV drawdown since its inception was -100.00%, roughly equal to the maximum TNYA drawdown of -98.69%. Use the drawdown chart below to compare losses from any high point for PSTV and TNYA.
Loading charts...
Drawdown Indicators
| PSTV | TNYA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -98.69% | -1.31% |
Max Drawdown (1Y)Largest decline over 1 year | -86.87% | -73.81% | -13.06% |
Max Drawdown (3Y)Largest decline over 3 years | -96.30% | -94.30% | -2.00% |
Max Drawdown (5Y)Largest decline over 5 years | -99.72% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -97.55% | -2.45% |
Average DrawdownAverage peak-to-trough decline | -79.52% | -82.23% | +2.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.48% | 48.71% | +4.77% |
Volatility
PSTV vs. TNYA - Volatility Comparison
The current volatility for Plus Therapeutics Inc (PSTV) is 17.29%, while Tenaya Therapeutics, Inc. (TNYA) has a volatility of 19.37%. This indicates that PSTV experiences smaller price fluctuations and is considered to be less risky than TNYA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PSTV | TNYA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.29% | 19.37% | -2.08% |
Volatility (6M)Calculated over the trailing 6-month period | 87.33% | 70.37% | +16.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 150.10% | 111.36% | +38.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 198.10% | 109.06% | +89.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 184.30% | 109.06% | +75.24% |
Dividends
PSTV vs. TNYA - Dividend Comparison
Neither PSTV nor TNYA has paid dividends to shareholders.
Financials
PSTV vs. TNYA - Financials Comparison
This section allows you to compare key financial metrics between Plus Therapeutics Inc and Tenaya Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PSTV and TNYA have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TNYA has higher volatility (19.37%) compared to PSTV (17.29%). In terms of maximum drawdown, PSTV dropped -100.00% vs TNYA's -98.69%.
TNYA currently has the higher Sharpe Ratio (0.27 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PSTV and TNYA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer